» Articles » PMID: 30076266

Non-motor Features of Parkinson's Disease in a Nested Case-control Study of US Men

Overview
Date 2018 Aug 5
PMID 30076266
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several non-motor features may individually contribute to identify prodromal Parkinson's disease (PD), but little is known on how they interact.

Methods: We conducted a case-control study nested within the Health Professionals Follow-up Study in a large cohort of men age 40-75 at recruitment in 1986. Cases (n=120) had confirmed PD, were<85 in January 2012, returned a 2012 questionnaire with questions on probable rapid eye movement sleep behaviour disorder (RBD) and constipation sent to all cohort participants and completed in 2014 the Brief Smell Identification Test and a questionnaire assessing parkinsonism and other non-motor PD features (including depressive symptoms, excessive daytime sleepiness, impaired colour vision and body pain). Controls (n=6479) met the same criteria as cases, except for the PD diagnosis.

Results: Concurrent constipation, probable RBD and hyposmia were present in 29.3% of cases and 1.1% of controls, yielding an age-adjusted OR of 160(95%CI 72.8to353) for three features versus none. The odds of PD increased exponentially with additional non-motor features (OR for 6-7 features versus none: 1325; 95%CI333to5279). Among men without PD, the number of non-motor features was associated with odds of parkinsonism (OR for 6-7 features versus none: 89; 95%CI21.2to375). We estimated that in a population with a prodromal PD prevalence of 2%, concurrent constipation, probable RBD and hyposmia would have a maximum sensitivity of 29% and a positive predictive value (PPV) of 35%. The PPV could increase up to 70% by including additional features, but with sharply decreased sensitivity.

Conclusions: Concurrent constipation, probable RBD and hyposmia are strongly associated with PD. Because these features often precede motor symptoms and their co-occurrence could provide an efficient method for early PD identification.

Citing Articles

Polygenic scores for disease risk are not associated with clinical outcomes in Parkinson's disease.

Tan M, Iwaki H, Bandres-Ciga S, Sosero Y, Shoai M, Brockmann K medRxiv. 2025; .

PMID: 39974079 PMC: 11838632. DOI: 10.1101/2025.01.31.25321395.


Identifying Individuals in the Prodromal Phase of Parkinson's Disease: A Prospective Cohort Study.

Flores-Torres M, Hughes K, Cortese M, Hung A, Healy B, Schwarzschild M Ann Neurol. 2024; 97(4):720-729.

PMID: 39702948 PMC: 11890925. DOI: 10.1002/ana.27166.


Urinary extracellular vesicle dynamics in Parkinson's disease patients with urinary dysfunction.

Roy S, Kashyap N, Anchan A, Punja D, Jasti D, Upadhya D Front Neurol. 2023; 14:1250832.

PMID: 38046591 PMC: 10691254. DOI: 10.3389/fneur.2023.1250832.


A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson's disease.

Chen X, Zhang Y Neural Regen Res. 2023; 19(2):324-330.

PMID: 37488885 PMC: 10503617. DOI: 10.4103/1673-5374.379042.


Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes.

Palacios N, Wilkinson J, Bjornevik K, Schwarzschild M, McIver L, Ascherio A Ann Neurol. 2023; 94(3):486-501.

PMID: 37314861 PMC: 10538421. DOI: 10.1002/ana.26719.